United Therapeutics continues to underperform Gilead by 44.8% in the past three months

Media coverage

• Title	United Therapeutics continues to underperform Gilead by 44.8% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	10/03/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to underperform Alnylam Pharmaceuticals by 10.2% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	10/03/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to underperform Regeneron by 4.2% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	10/03/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to underperform Amgen by 31.9% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	10/03/25
  Persons	Jeffrey Klein